Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer

Hong-bo ZHU,Xue-feng HUANG,Jing-zi HU,Wei ZHOU,Wei CHEN,Lin-lin CHEN,Chao HE

DOI: https://doi.org/10.3321/j.issn:0253-3766.2008.04.002

2008-01-01

Abstract:Objective To investigate the reversing effct of Bcl-XL small interfering RNA(siRNA)on the acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) in human colon cancer.Methods Human colon cancer cells DLDl.TRAIL/R,with acquired resistance to TRAIL,were firstly transfected with Bcl-XL siRNA for 24 h followed by the treatment of TRAIL protein.The survival rate of DLD1-TRAIL/R cells was assessed by FACS analysis and cell number counting,respectively,and activation of its apoptotic signaling was evaluated by Western blot.Results Bcl-XL siRNA effectivelv down regulated the expression of Bcl-XL protein and reversed the acquired resistance to TRAIL in DLD1-TRAIL/R cells-After combination treatment of Bcl-XL siRNA and TRAIL protein.the apoptotic rate of DLD1-TRAIL/R eells was more than 50%and survival rate was less than 40%,whereas there was no efiect on the survival of DLD1-TRAIL/R cells after treatment with control treatment or TRAIL protein treatment alone ( P＜0.05).Western blot analysis demonstrated that caspase-8,caspase-9,Bid,caspase-3,and p01y(ADPribose)polymerase(PARP)were obviously activated after combination treatment with Bcl-XL siRNA and TRAIL protein,and the release of cytochrome C was also significantly increased.Conclusion Bcl-XLsiRNA can effectively reverse the acquired resistance to TRAIL in human colon cancer cells,suggesting that it might be a new strategy for overcoming the resistance in cancer therapy.